Journal of Bone and Mineral Metabolism

, Volume 28, Issue 6, pp 608–616 | Cite as

Treatment of experimental osteonecrosis of the hip in adult rabbits with a single local injection of recombinant human FGF-2 microspheres

  • Yutaka Kuroda
  • Haruhiko Akiyama
  • Keiichi Kawanabe
  • Yasuhiko Tabata
  • Takashi Nakamura
Original Article
First Online:
Received:
Accepted:

Abstract

Basic fibroblast growth factor (FGF-2) exerts anabolic actions on bone formation. Here we investigated the potential effects of recombinant human FGF-2 (rhFGF-2) on the repair process of osteonecrosis of the femoral head (ONFH) and the development of secondary osteoarthritis (OA) in adult rabbits. ONFH was induced by intramuscular injection with methylprednisolone, and vascular occlusion of the capital femoral epiphysis by electrocoagulation, in adult Japanese white rabbits. Animals were randomized into two groups: treatment and control. The treatment group was given a single local injection into the femoral head of 100 μg rhFGF-2 in 100 μl gelatin hydrogel microspheres 8 weeks after the ONFH procedure, and the control group was given phosphate-buffered saline in 100 μl gelatin hydrogel microspheres. Morphological, histopathological, and radiologic analyses, including micro-computed tomography scans and magnetic resonance imaging, showed collapse of the femoral head and progression of articular cartilage degeneration in the control group at 16 weeks after the single local injection of rhFGF-2. In contrast, rhFGF-2 treatment resulted in new bone formation in the femoral head and prevented the femoral head from collapsing. In addition, the changes in OA, assessed by the modified Mankin score, was significantly lower in the treatment group. Our results indicate that a single local injection of rhFGF-2 microspheres promoted the repair of the osteonecrotic femoral head and inhibited femoral head collapse and OA progression. rhFGF-2 may be a promising strategy for the treatment of ONFH.

Keywords

FGF-2 Single local injection Osteonecrosis Osteoarthritis Femoral head 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Hernigou P, Ooignard A, Nogier A, Manicom O (2004) Fate of very small asymptomatic stage-I osteonecrotic lesions of the hip. J Bone Joint Surg Am 86:2589–2593PubMedGoogle Scholar
  2. 2.
    Mont MA, Jones LC, Hngerford DS (2006) Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am 88:1117–1132CrossRefPubMedGoogle Scholar
  3. 3.
    Marker DR, Seylee TM, McGrath MS, Delanois RE, Ulrich SD, Mont MA (2008) Treatment of early stage osteonecrosis of the femoral head. J Bone Joint Surg Am 90:175–187CrossRefPubMedGoogle Scholar
  4. 4.
    Mont MA, Jones LC, Einhorn TA, Hungerford DS, Reddi AH (1998) Osteonecrosis of the femoral head: potential treatment with growth and differentiation factors. Clin Orthop Relat Res 355:314–335CrossRefGoogle Scholar
  5. 5.
    Lieberman JR, Conduah A, Urist MR (2004) Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop Relat Res 429:139–145CrossRefPubMedGoogle Scholar
  6. 6.
    Gangji V, Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, Lambermont M (2004) Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells: a pilot study. J Bone Joint Surg Am 86:1153–1160PubMedGoogle Scholar
  7. 7.
    Hernigou P, Beaujean F (2002) Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res 405:14–23CrossRefPubMedGoogle Scholar
  8. 8.
    Desai MM, Sonone S, Bhasme V (2005) Efficacy of alendronate in the treatment of avascular necrosis of the hip. Rheumatology 44:1331–1332CrossRefPubMedGoogle Scholar
  9. 9.
    Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM (2005) The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. J Bone Joint Surg Am 87:2155–2159CrossRefPubMedGoogle Scholar
  10. 10.
    Cui Q, Wang CJ, Su CC, Balian G (1997) Lovastatin prevents steroid induced adipogenesis and osteonecrosis. Clin Orthop Relat Res 344:8–19CrossRefPubMedGoogle Scholar
  11. 11.
    Pritchett JW (2001) Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res 386:173–178CrossRefPubMedGoogle Scholar
  12. 12.
    Canalis E, Centrella M, McCarthy T (1988) Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest 81:1572–1577CrossRefPubMedGoogle Scholar
  13. 13.
    Lieberman JR, Daluiski A, Einhorn TA (2002) The role of growth factors in the repair of bone biology and clinical applications. J Bone Joint Surg Am 84:1032–1044PubMedGoogle Scholar
  14. 14.
    Itoh N, Orniz DM (2004) Evolution of the Fgf and Fgfr gene families. Trends Genet 20:563–569CrossRefPubMedGoogle Scholar
  15. 15.
    Kato T, Kawaguchi H, Hanada K, Aoyama Y, Nakamura T, Kuzutani K, Tamura M, Kurokawa T, Nakamura K (1998) Single local injection of recombinant fibroblast growth factor-2 stimulates healing of segmental bone defects in rabbit. J Orthop Res 16:654–659CrossRefPubMedGoogle Scholar
  16. 16.
    Nakamura T, Hara Y, Tagawa M, Yuge T, Fukuda H, Nigi H (1998) Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture. J Bone Miner Res 13:942–949CrossRefPubMedGoogle Scholar
  17. 17.
    Chen WJ, Jingushi W, Aoyama I, Anzai J, Hirata G, Tamura M, Iwamoto Y (2004) Effects of FGF-2 on metaphyseal fracture in rabbit tibiae. J Bone Miner Metab 22:303–309CrossRefPubMedGoogle Scholar
  18. 18.
    Tabata Y, Nagano A, Ikada Y (1999) Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng 5:127–147CrossRefPubMedGoogle Scholar
  19. 19.
    Yamamoto M, Ikeda Y, Tabata Y (2001) Controlled release of growth factors based on biodegradation of gelatin hydrogel. J Biomater Sci Polym Ed 12:77–88CrossRefPubMedGoogle Scholar
  20. 20.
    Tabata Y (2003) Tissue regeneration based on growth factor release. Tissue Eng 9(suppl 1):S5–S15CrossRefPubMedGoogle Scholar
  21. 21.
    Tabata Y, Yamada K, Miyamoto S, Nagata I, Kikuchi H, Aoyama I, Tamura M, Ikada Y (1998) Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogel. Biomaterials 19:807–815CrossRefPubMedGoogle Scholar
  22. 22.
    Tabata Y, Hijikata S, Muniruzzaman M, Ikada Y (1999) Neovascularization through biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J Biomater Sci Polym Ed 10:79CrossRefPubMedGoogle Scholar
  23. 23.
    Sakakibara Y, Nishimura K, Tambara K, Yamamoto M, Lu F, Tabata Y, Komeda M (2001) Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J Thorac Cardiovasc Surg 124:50CrossRefGoogle Scholar
  24. 24.
    Kawaguchi H, Jingushi S, Izumi M, Fukunaga M, Matsushita T, Nakamura T, Mizuno K, Nakamura T, Nakamura K (2007) Local application of recombinant human fibroblast growth factor-2 on bone repair: a dose-escalation prospective trial on patients with osteotomy. J Orthop Res 25:480–487CrossRefPubMedGoogle Scholar
  25. 25.
    Tabata Y, Yamada K, Hong L, Miyamoto S, Hashimoto N, Ikada Y (1999) Skull bone regeneration in primates in response to basic fibroblast growth factor. J Neurosurg 91:851CrossRefPubMedGoogle Scholar
  26. 26.
    Norman D, Reis D, Zinman G, Misselevich I, Boss JH (1998) Vascular deprivation-induced necrosis of the femoral head of the rat. An experimental model of avascular osteonecrosis in the skeletally immature individual or Legg–Perthes disease. Int J Exp Pathol 79:173–181CrossRefPubMedGoogle Scholar
  27. 27.
    Hofstaetter JG, Wang J, Yan J, Glimcher MJ (2009) The effects of allendronate in the treatment of experimental osteonecrosis of the hip on adult rabbits. Osteoarthritis Cartil 17:362–370CrossRefGoogle Scholar
  28. 28.
    Okano K, Enomoto H, Osaki M, Shindo H (2008) Rotational acetabular osteotomy for advanced osteoarthritis secondary to developmental dysplasia of the hip. J Bone Joint Surg Br 90:23–26PubMedGoogle Scholar
  29. 29.
    Magnussen RA, Guilak F, Vail TP (2005) Articular cartilage degeneration in post-collapse osteonecrosis of the femoral head. Radiographic staging, macroscopic grading, and histologic changes. J Bone Joint Surg Am 87:1272–1277CrossRefPubMedGoogle Scholar
  30. 30.
    Ficat RP, Arlet J (1980) Functional investigation of bone under normal conditions. In: Hungerford DS (ed) Ischemia and necrosis of bone. Williams & Wilkins, Baltimore, pp 29–52Google Scholar
  31. 31.
    Otsu N (1979) A threshold selection method from gray-level histograms. IEEE Trans Syst Man Cybern 9:62–66CrossRefGoogle Scholar
  32. 32.
    Mankin HJ, Dorfman H, Lippiello L, Zarins A (1971) Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 53:523–537PubMedGoogle Scholar
  33. 33.
    Shida JI, Jingushi S, Izumi T, Ikenoue T, Iwamoto Y (2001) Basic fibroblast growth factor regulates expression of growth factors in rat epiphyseal chondrocytes. J Orthop Res 19:259–264CrossRefPubMedGoogle Scholar
  34. 34.
    Kawaguchi H, Pilbeam CC, Gronowicz G, Abreu C, Fletcher BS, Herschman HR, Raisz LG, Hurley MM (1995) Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor. J Clin Invest 96:923–930CrossRefPubMedGoogle Scholar
  35. 35.
    Collin-Osdoby P, Rothe L, Bekker S, Anderson F, Huang Y, Osdoby P (2002) Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro. J Bone Miner Res 17:1859–1871CrossRefPubMedGoogle Scholar
  36. 36.
    Chikazu D, Hakeda Y, Ogata N, Nemoto K, Itabashi A, Takato T, Kumegawa M, Nakamura K, Kawaguchi H (2000) Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase. J Biol Chem 6:31444–31450CrossRefGoogle Scholar
  37. 37.
    Komaki H, Tanaka T, Chazono M, Kikuchi T (2006) Repair of segmental defects in rabbit tibiae using a complex β-tricalcium phosphate, type I collagen, and fibroblast growth factor-2. Biomaterials 27:5118–5126CrossRefPubMedGoogle Scholar
  38. 38.
    Tsurushima H, Marushima A, Suzuki K, Oyane A, Sogo Y, Nakamura K, Matsumura A, Ito A (2010) Enhanced bone formation using hydroxyapatite ceramic coated with fibroblast growth factor-2. Acta Biomater doi: 10.1016/j.actbio.2009.12.045
  39. 39.
    Hungerford MW, Mont MA (2000) Potential uses of cytokines and growth factors in treatment of osteonecrosis. Orthopade 29:442–448CrossRefPubMedGoogle Scholar
  40. 40.
    D’Amore PA, Smith SR (1993) Growth factor effects on cells of the vascular wall: a survey. Growth Factors 8:61–75CrossRefPubMedGoogle Scholar
  41. 41.
    Ferrara N, Henzel WJ (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851–858CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society for Bone and Mineral Research and Springer 2010

Authors and Affiliations

  • Yutaka Kuroda
    • 1
  • Haruhiko Akiyama
    • 1
  • Keiichi Kawanabe
    • 1
  • Yasuhiko Tabata
    • 2
  • Takashi Nakamura
    • 1
  1. 1.Department of Orthopaedic Surgery, Graduate School of MedicineKyoto UniversityKyotoJapan
  2. 2.Department of Biomaterials, Field of Tissue Engineering, Institute for Frontier, Medical SciencesKyoto UniversityKyotoJapan

Personalised recommendations